2118 — Advance, North Carolina

2118 is a clinical research site located in Advance, North Carolina, United States.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

2118 has participated in 1 clinical trials.

Therapeutic areas: Advanced Idiopathic Parkinson's Disease.

Sponsors: UCB BIOSCIENCES GmbH.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 2118?

2118 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 2118 conducted?

2118 has 1 clinical trials on record. Their work covers Advanced Idiopathic Parkinson's Disease.

Is 2118 accredited by Crixeo Health?

2118 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 2118?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.